BUSINESS

Companies Announce Conference Participation and Financial Reporting Schedule

PUBLISHED Mar 10, 2026, 8:32 AM ET

Read, Watch or Listen

Media Bias Meter

Sources: 13

Center 100%

Sources: 13

Austin, Texas — Multiple companies announced conference participation, earnings calls, and regulatory updates this week globally. Genprex said executives will attend BIO Europe Spring in Lisbon March 23–25 to meet industry groups. Spectral AI scheduled fourth-quarter and full-year 2025 results and a March 24 conference call. Co-Diagnostics confirmed Nasdaq compliance on March 9 and will resume trading March 11. byNordic extended its SPAC combination deadline to April 12 by depositing $17,470. Innovative Eyewear set an earnings call for March 31 with a replay available. GT Biopharma will present at the Roth Conference March 24. Based on 6 articles reviewed and supporting research.

By Yusra M. | JQJO News

Timeline of Events

March 9, 2026 — Co-Diagnostics received formal Nasdaq notice regaining compliance.
March 10, 2026 — Genprex announced executives will attend BIO Europe Spring March 23–25 in Lisbon.
March 10, 2026 — Spectral AI scheduled Q4 and full-year 2025 results release and March 24 call.
March 10, 2026 — byNordic deposited $17,470 to extend SPAC combination deadline to April 12, 2026.
March 11, 2026 — GT Biopharma announced a March 24 presentation at the Roth Conference; Innovative Eyewear set a March 31 earnings call.

News Intelligence

These updates affect your investments. Genprex, Spectral AI, Co-Diagnostics, byNordic, Innovative Eyewear, and GT Biopharma are all making moves. If you own shares, watch their earnings calls and conference presentations. It's your money on the line.

Media Bias

Articles Published:: 13
Right Leaning:: 0
Left Leaning:: 0
Neutral:: 13
Distribution:: Left 0%, Center 100%, Right 0%

Who Benefited

Biotech and diagnostics companies announcing events and compliance outcomes gained visibility with investors, enabling management teams to engage industry stakeholders, clarify timelines, and potentially support future fundraising or partnership discussions.

Who Impacted

Shareholders and retail investors in entities with pending corporate actions face short-term uncertainty; byNordic SPAC investors confront repeated deadline extensions and limited additional time to evaluate a potential business combination.